المؤلفون: Alessia Tieghi, Alessandra D'Addio, Florian H. Heidel, Roberto Latagliata, Elisa Bossi, Francesco Cavazzini, Giulia Benevolo, Nicola Vianelli, Michele Cavo, Roberto M. Lemoli, Mauro Krampera, Massimo Breccia, Massimiliano Bonifacio, Gianni Binotto, Antonio Cuneo, Giovanni Caocci, Daniela Bartoletti, Mario Tiribelli, Ida Carmosino, Lucia Catani, Giuseppe Auteri, Francesco Lanza, Giuseppe A. Palumbo, Nicola Polverelli, Francesca Palandri, Micaela Bergamaschi, Monica Crugnola, Elena Maria Elli

المساهمون: Benevolo G., Elli E.M., Bartoletti D., Latagliata R., Tiribelli M., Heidel F.H., Cavazzini F., Bonifacio M., Crugnola M., Binotto G., D'Addio A., Tieghi A., Bergamaschi M., Caocci G., Polverelli N., Bossi E., Auteri G., Carmosino I., Catani L., Cuneo A., Krampera M., Lanza F., Lemoli R.M., Vianelli N., Breccia M., Palumbo G.A., Cavo M., Palandri F.

المصدر: Hematological Oncology. 39:409-418

مصطلحات موضوعية: Male, Cancer Research, Comorbidity, Overweight, Primary Myelofibrosi, 0302 clinical medicine, Retrospective Studie, Risk Factors, body mass index, cancer, Charlson comorbidity index, outcome, polycythemia vera, thrombotic risk, 80 and over, Cumulative incidence, Aged, 80 and over, Incidence, Incidence (epidemiology), Hazard ratio, Hematology, General Medicine, Middle Aged, Oncology, 030220 oncology & carcinogenesis, Thrombosi, Female, Underweight, medicine.symptom, Human, Adult, medicine.medical_specialty, NO, Follow-Up Studie, 03 medical and health sciences, Internal medicine, medicine, Humans, Aged, Retrospective Studies, business.industry, Risk Factor, Thrombosis, Retrospective cohort study, medicine.disease, Follow-Up Studies, Polycythemia Vera, Primary Myelofibrosis, Body Mass Index, Body Mass Index, Cancer, Charlson Comorbidity Index, Outcome, Polycythemia Vera, Thrombotic risk, business, Body mass index, 030215 immunology

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3939263de47b0f932025c0ddc18dfcTest
https://doi.org/10.1002/hon.2843Test

المؤلفون: Hani Hassoun, Jacob P. Laubach, Jan S. Moreb, Sara Thuresson, Paula Rodriguez-Otero, Marcus Thuresson, Michele Cavo, Albert Oriol, Maria-Victoria Mateos, Joan Bladé, John W. Hiemenz, Adrian Alegre, Amitabha Mazumder, Horizon (Op ) Investigators, Kenneth C. Anderson, Omar Nadeem, Johan Harmenberg, Nicolaas A Bakker, Xavier Leleu, Alessandra Larocca, Christopher Maisel, Paul G. Richardson, Agne Paner, Anastasios Raptis, Cyrille Touzeau, Catriona Byrne

المساهمون: Harvard Medical School [Boston] (HMS), Hospital Universitari Germans Trias I Pujol [Badalona], Università degli studi di Torino = University of Turin (UNITO), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), University of Bologna/Università di Bologna, Clínica Universidad de Navarra [Pamplona], Centre hospitalier universitaire de Poitiers (CHU Poitiers), University of Florida [Gainesville] (UF), Memorial Sloane Kettering Cancer Center [New York], Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma (CRCINA-ÉQUIPE 10), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Université d'Angers (UA), Université de Nantes (UN), Site de Recherche Intégrée sur le Cancer [Nantes] (SIRIC), Centre hospitalier universitaire de Nantes (CHU Nantes), SIRIC ILIAD [Angers, Nantes], Hospital Universitario Quironsalud, Rush University Medical Center [Chicago], Baylor Scott & White Charles A. Sammons Cancer Center [Dallas, TX, USA], Oncology Institute of Hope and Innovation [Glendale, CA, USA] (OIHI), University of Pittsburgh School of Medicine, Pennsylvania Commonwealth System of Higher Education (PCSHE), Novant Health Forsyth Medical Center [Winston-Salem, NC, USA] (NHFMC), Oncopeptides AB [Stockholm, Sweden], Instituto de Investigación Biomédica de Salamanca [Salamanca, Spain] (IBSAL/CIC), HORIZON (OP-106) Investigators, Bernardo, Elizabeth, Università degli studi di Torino (UNITO), University of Bologna, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Richardson P.G., Oriol A., Larocca A., Blade J., Cavo M., Rodriguez-Otero P., Leleu X., Nadeem O., Hiemenz J.W., Hassoun H., Touzeau C., Alegre A., Paner A., Maisel C., Mazumder A., Raptis A., Moreb J.S., Anderson K.C., Laubach J.P., Thuresson S., Thuresson M., Byrne C., Harmenberg J., Bakker N.A., Mateos M.-V.

المصدر: Journal of Clinical Oncology
Journal of Clinical Oncology, 2021, 39 (7), pp.757-767. ⟨10.1200/JCO.20⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2021, 39 (7), pp.757-767. ⟨10.1200/JCO.20⟩
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

مصطلحات موضوعية: Adult, Male, Cancer Research, Time Factors, Time Factor, Phenylalanine, [SDV.CAN]Life Sciences [q-bio]/Cancer, Tumor cells, Drug resistance, Dexamethasone, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Recurrence, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm, Progression-free survival, Melphalan, Aged, 030304 developmental biology, Aged, 80 and over, 0303 health sciences, Antineoplastic Combined Chemotherapy Protocol, business.industry, Refractory Multiple Myeloma, Middle Aged, medicine.disease, Progression-Free Survival, United States, 3. Good health, Europe, Clinical trial, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Disease Progression, Cancer research, Female, Multiple Myeloma, business, Human, Conjugate, medicine.drug

وصف الملف: application/pdf; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79bb7c110aefa09f245d7dfe112c3ba4Test
https://doi.org/10.1200/jco.20.02259Test

المؤلفون: Michele Cavo, Ioannis Ntanasis-Stathopoulos, Charalampia Kyriakou, Brian G.M. Durie, Jesús F. San-Miguel, Fredrik Schjesvold, Philippe Moreau, Sonja Zweegman, Noopur Raje, Evangelos Terpos, Nikhil C. Munshi, Matthew T. Drake, Meletios A. Dimopoulos, Elena Zamagni, Suzanne Lentzsch, Niels Abildgaard, Jens Hillengass, Javier de la Rubia, Ramón García-Sanz

المساهمون: Terpos E., Zamagni E., Lentzsch S., Drake M.T., Garcia-Sanz R., Abildgaard N., Ntanasis-Stathopoulos I., Schjesvold F., de la Rubia J., Kyriakou C., Hillengass J., Zweegman S., Cavo M., Moreau P., San-Miguel J., Dimopoulos M.A., Munshi N., Durie B.G.M., Raje N.

المصدر: Terpos, E, Zamagni, E, Lentzsch, S, Drake, M T, García-Sanz, R, Abildgaard, N, Ntanasis-Stathopoulos, I, Schjesvold, F, de la Rubia, J, Kyriakou, C, Hillengass, J, Zweegman, S, Cavo, M, Moreau, P, San-Miguel, J, Dimopoulos, M A, Munshi, N, Durie, B G M, Raje, N & Bone Working Group of the International Myeloma Working Group 2021, ' Treatment of multiple myeloma-related bone disease : recommendations from the Bone Working Group of the International Myeloma Working Group ', The Lancet Oncology, vol. 22, no. 3, pp. e119-e130 . https://doi.org/10.1016/S1470-2045Test(20)30559-3
Bone Working Group of the International Myeloma Working Group 2021, ' Treatment of multiple myeloma-related bone disease : recommendations from the Bone Working Group of the International Myeloma Working Group ', The Lancet Oncology, vol. 22, no. 3, pp. e119-e130 . https://doi.org/10.1016/S1470-2045Test(20)30559-3

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Bone Density Conservation Agent, Bone disease, 03 medical and health sciences, 0302 clinical medicine, Spinal cord compression, medicine, Humans, Multiple myeloma, Bone Density Conservation Agents, business.industry, medicine.disease, Surgery, Discontinuation, Transplantation, 030104 developmental biology, Zoledronic acid, Denosumab, Oncology, 030220 oncology & carcinogenesis, Practice Guidelines as Topic, Bone Diseases, business, Bone Disease, Multiple Myeloma, medicine.drug, Human

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::087f0958cccbc7e19db18e9c77a57d23Test
http://www.scopus.com/inward/record.url?scp=85101284824&partnerID=8YFLogxKTest

المؤلفون: Samantha Bruno, Claudio Franceschi, Francesco Fabbri, Giorgia Simonetti, Erika Bandini, Maria Chiara Deregibus, Lucia Catani, Nicola Vianelli, Daria Sollazzo, Dorian Forte, Francesca Palandri, Cristina Morsiani, Emanuela Ottaviani, Michele Cavo, Martina Barone, Giuseppe Auteri, Giovanni Camussi, Miriam Capri, Salvatore Collura

المساهمون: Forte D., Barone M., Morsiani C., Simonetti G., Fabbri F., Bruno S., Bandini E., Sollazzo D., Collura S., Deregibus M.C., Auteri G., Ottaviani E., Vianelli N., Camussi G., Franceschi C., Capri M., Palandri F., Cavo M., Catani L.

المصدر: Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-14 (2021)
Journal of Experimental & Clinical Cancer Research : CR

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, CD34, Inflammation, microRNA, Myelofibrosis, Antigens, CD34, Inflammation, Biology, Severity of Illness Index, lcsh:RC254-282, Immunophenotyping, Proinflammatory cytokine, Flow cytometry, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Progenitor cell, Cells, Cultured, medicine.diagnostic_test, Inflammation, microRNAs, Research, Gene Expression Profiling, Interleukin, Janus Kinase 2, Extracellular vesicles, Hematopoietic Stem Cells, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Mitochondria, Haematopoiesis, 030104 developmental biology, Oncology, Primary Myelofibrosis, 030220 oncology & carcinogenesis, Mutation, Disease Progression, Cancer research, Cytokines, Female, Tumor necrosis factor alpha, Inflammation Mediators, medicine.symptom, Extracellular vesicle, Biomarkers

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e7b8d5cc66263431f8f8dfb45666ddTest
https://doaj.org/article/ea1e5111da3d4f6c9597a0561836a070Test

المؤلفون: Elena Zamagni, Cristina Nanni, Luca Dozza, Thomas Carlier, Clément Bailly, Paola Tacchetti, Annibale Versari, Stephane Chauvie, Andrea Gallamini, Barbara Gamberi, Denis Caillot, Francesca Patriarca, Margaret Macro, Mario Boccadoro, Laurent Garderet, Simona Barbato, Stefano Fanti, Aurore Perrot, Francesca Gay, Peter Sonneveld, Lionel Karlin, Michele Cavo, Caroline Bodet-Milin, Philippe Moreau, Françoise Kraeber-Bodéré

المساهمون: Zamagni E., Nanni C., Dozza L., Carlier T., Bailly C., Tacchetti P., Versari A., Chauvie S., Gallamini A., Gamberi B., Caillot D., Patriarca F., Macro M., Boccadoro M., Garderet L., Barbato S., Fanti S., Perrot A., Gay F., Sonneveld P., Karlin L., Cavo M., Bodet-Milin C., Moreau P., Kraeber-Bodere F., Bernardo, Elizabeth, The Institute of Hematology and Oncology L. and A. Seràgnoli [Bologna, Italy], Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO), Policlinico S. Orsola-malpighi, Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO)-Servizio sanitario regionale Emilia-Romagna, Nuclear Oncology (CRCINA-ÉQUIPE 13), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Santa Croce e Carle Hospital [Cuneo, Italy], Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Service d'Hématologie Clinique (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Università degli Studi di Udine - University of Udine [Italie], Laboratoire d'Hématologie Biologique [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Università degli studi di Torino = University of Turin (UNITO), Service d'Hématologie clinique [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Erasmus University Medical Center [Rotterdam] (Erasmus MC), Service d’Hématologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Service d'Hématologie [Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Università degli Studi di Modena e Reggio Emilia, Università degli studi di Torino (UNITO), Hematology

المصدر: Journal of Clinical Oncology
Journal of Clinical Oncology, 2020, 38, Online ahead of print. ⟨10.1200/JCO.20.00386⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38, Online ahead of print. ⟨10.1200/JCO.20.00386⟩
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(2), 116-125

مصطلحات موضوعية: Cancer Research, [SDV.CAN]Life Sciences [q-bio]/Cancer, Computed tomography, Newly diagnosed, 18F-Fluorodeoxyglucose, FDG, positron emission tomography, PET, computed tomography, CT, minimal residual disease, multiple myeloma, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Deauville Criteria, 18 F-FDG-PET/CT, Medicine, Multiple myeloma, Complete response, 18F-FDG-PET/C, Multiple Myeloma, medicine.diagnostic_test, business.industry, medicine.disease, Standard technique, Minimal residual disease, Oncology, Positron emission tomography, 030220 oncology & carcinogenesis, Fdg pet ct, 18F-FDG, myeloma, Deauville, Nuclear medicine, business, 030215 immunology

وصف الملف: STAMPA; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d330feb2ab88afd3cc0d9d8d8558443Test
https://doi.org/10.1200/jco.20.00386Test

المؤلفون: Paola Tacchetti, Lucia Pantani, Francesca Patriarca, Maria Teresa Petrucci, Elena Zamagni, Luca Dozza, Monica Galli, Francesco Di Raimondo, Claudia Crippa, Mario Boccadoro, Simona Barbato, Patrizia Tosi, Franco Narni, Vittorio Montefusco, Nicoletta Testoni, Antonio Spadano, Carolina Terragna, Norbert Pescosta, Giulia Marzocchi, Claudia Cellini, Piero Galieni, Sonia Ronconi, Marco Gobbi, Lucio Catalano, Antonio Lazzaro, Giovanni De Sabbata, Clotilde Cangialosi, Fabrizio Ciambelli, Pellegrino Musto, Francesca Elice, Michele Cavo, Renato Fanin, Roberto Foa', Alessandro Rambaldi, Giuseppe Rossi, Pietro Leoni, Paolo Corradini, Giuseppe Torelli, Giuseppe Fioritoni, Sergio Cortelazzo, Giorgio Lambertenghi Deliliers, Giorgio La Nasa, Alfonso Zaccaria, Paolo De Fabritiis, Nicola Cascavilla, Alberto Bosi, Gianpietro Semenzato, Luigi Gugliotta, Filippo Gherlinzoni, Emanuele Angelucci, Massimo Fabrizio Martelli, Maria Concetta Petti, Giuseppe Leone, Angelo Michele Carella, Fabio Ciceri, Armando Santoro, Felicetto Ferrara, Francesco Nobile, Alfonso Maria D'Arco, Alessandro Levis, Luciano Guardigni, Andrea Gallamini, Pier Paolo Fattori, Sergio Morandi, Dino Amadori, Bruno Rotoli, Salvatore Mirto, Giorgio Paladini, Ruggero Mozzana, Graziella Pinotti, Francesco Rodeghiero, Nicola Cantore, Vincenzo Pavone, Enrico Maria Pogliani, Anna Marina Liberati, Ignazio Majolino, Sergio Amadori, Francesco Lauria, Massimo Aglietta, Giovanni Quarta, Sergio Storti, Fortunato Morabito, Silvana Franca Capalbo, Alessandro Massimo Gianni, Vincenzo Mettivier, Vittorio Rizzoli, Carlo Bernasconi, Giuseppe Visani, Michele Pizzuti, Giacinto La Verde, Giuseppe Avvisati, Maurizio Longinotti, Eugenio Gallo, Franco Dammacco, Domenico Russo, Andrea Bacigalupo, Caterina Musolino

المساهمون: Tacchetti P., Pantani L., Patriarca F., Petrucci M.T., Zamagni E., Dozza L., Galli M., Di Raimondo F., Crippa C., Boccadoro M., Barbato S., Tosi P., Narni F., Montefusco V., Testoni N., Spadano A., Terragna C., Pescosta N., Marzocchi G., Cellini C., Galieni P., Ronconi S., Gobbi M., Catalano L., Lazzaro A., De Sabbata G., Cangialosi C., Ciambelli F., Musto P., Elice F., Cavo M., Fanin R., Foa' R., Rambaldi A., Rossi G., Leoni P., Corradini P., Torelli G., Fioritoni G., Cortelazzo S., Lambertenghi Deliliers G., La Nasa G., Zaccaria A., De Fabritiis P., Cascavilla N., Bosi A., Semenzato G., Gugliotta L., Gherlinzoni F., Angelucci E., Martelli M.F., Petti M.C., Leone G., Carella A.M., Ciceri F., Santoro A., Ferrara F., Nobile F., D'Arco A.M., Levis A., Guardigni L., Gallamini A., Fattori P.P., Morandi S., Amadori D., Rotoli B., Mirto S., Paladini G., Mozzana R., Pinotti G., Rodeghiero F., Cantore N., Pavone V., Pogliani E.M., Liberati A.M., Majolino I., Amadori S., Lauria F., Aglietta M., Quarta G., Storti S., Morabito F., Capalbo S.F., Gianni A.M., Mettivier V., Rizzoli V., Bernasconi C., Visani G., Pizzuti M., La Verde G., Avvisati G., Longinotti M., Gallo E., Dammacco F., Russo D., Bacigalupo A., Musolino C.

المصدر: The Lancet Haematology. 7:e861-e873

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, Adolescent, Phases of clinical research, Transplantation, Autologous, Dexamethasone, Bortezomib, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, GIMEMA-MMY-3006 trial, bortezomib, thalidomide, dexamethasone, VTD, double autologous haematopoietic stem-cell transplantation, multiple myeloma, Multiple myeloma, Aged, Intention-to-treat analysis, business.industry, Hazard ratio, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, medicine.disease, Thalidomide, Transplantation, Regimen, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, business, Follow-Up Studies, 030215 immunology, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d247cf6931cb796a2568e2552250ca02Test
https://doi.org/10.1016/s2352-3026Test(20)30323-9

المؤلفون: Michele Cavo, Vania Hungria, Bart Heeg, Andrea Garcia, Meletios A. Dimopoulos, Mariana Fernandez, Deborah M. Martínez-Baños, Maria-Victoria Mateos, Jianming He, Gerardo Machnicki, Annette Lam

المساهمون: Hungria V., Martinez-Banos D.M., Mateos M.-V., Dimopoulos M.A., Cavo M., Heeg B., Garcia A., Lam A., Machnicki G., He J., Fernandez M.

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Melphalan, 030213 general clinical medicine, medicine.medical_specialty, Population, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Multiple myeloma, Daratumumab, Propensity score matching, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Pharmacology (medical), Propensity Score, education, Aged, Retrospective Studies, Original Research, education.field_of_study, business.industry, Antibodies, Monoclonal, Standard of Care, General Medicine, Middle Aged, medicine.disease, Progression-Free Survival, Confidence interval, Hemato-Oncology Latin America, Latin America, ALYCONE, 030220 oncology & carcinogenesis, Cohort, Prednisone, Indirect treatment comparison, Female, business, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d30dae92d709ef6526889f33c6e8d32bTest
https://doi.org/10.1007/s12325-020-01521-9Test

المؤلفون: Giovannella Palmieri, Piotr Czaykowski, Lucia Nappi, Sabino De Placido, Denis Soulières, Marianna Tortora, Maria Cossu Rocca, Giulia Baciarello, Christina Canil, Margaret Ottaviano, Paolo Andrea Zucali, Jourik A. Gietema, Bruno Vincenzi, Pasquale Rescigno, Sebastien J. Hotte, Franco Morelli, Umberto Basso, Christoph Oing, Giuseppe Luigi Banna, Simona Secondino, Giuseppe Fornarini, Christian Kollmannsberger, Alessia Cavo, Xavier Garcia del Muro, Franco Nolè, Craig R. Nichols, Teodoro Sava, Ugo De Giorgi, Marco Maruzzo, Carlo Messina, Giuseppe Simone, Daniel Y.C. Heng, Marilena Di Napoli, Sasja F. Mulder

المساهمون: Nappi, Lucia, Ottaviano, Margaret, Rescigno, Pasquale, Tortora, Marianna, Banna, Giuseppe L, Baciarello, Giulia, Basso, Umberto, Canil, Christina, Cavo, Alessia, Cossu Rocca, Maria, Czaykowski, Piotr, De Giorgi, Ugo, Garcia Del Muro, Xavier, Di Napoli, Marilena, Fornarini, Giuseppe, Gietema, Jourik A, Heng, Daniel Y C, Hotte, Sebastien J, Kollmannsberger, Christian, Maruzzo, Marco, Messina, Carlo, Morelli, Franco, Mulder, Sasja, Nichols, Craig, Nolè, Franco, Oing, Christoph, Sava, Teodoro, Secondino, Simona, Simone, Giuseppe, Soulieres, Deni, Vincenzi, Bruno, Zucali, Paolo A, De Placido, Sabino, Palmieri, Giovannella, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)

المصدر: The Oncologist, 25(10), e1509-e1515. ALPHAMED PRESS
Oncologist

مصطلحات موضوعية: Curable tumor, Canada, Cancer Research, medicine.medical_specialty, Germ cell tumors, Disease, Expert centers, Genitourinary Cancer, 03 medical and health sciences, 0302 clinical medicine, Testicular cancer, Granulocyte Colony-Stimulating Factor, Epidemiology, Health care, Pandemic, Germ cell tumor, medicine, Surveys and Questionnaire, Expert center, 030212 general & internal medicine, Practice Patterns, Physicians', Curable tumors, Cancer Care Facilitie, SARS-CoV-2, business.industry, Public health, COVID-19, Cancer Care Facilities, Neoplasms, Germ Cell and Embryonal, medicine.disease, Telemedicine, Europe, Oncology, 030220 oncology & carcinogenesis, Family medicine, Oncologist, business, Human

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a661cf2f9aca2128e37317dcdaff7542Test
https://doi.org/10.1634/theoncologist.2020-0420Test

المؤلفون: Darina Ocadlikova, Mariangela Lecciso, Javier Martin Broto, Katia Scotlandi, Michele Cavo, Antonio Curti, Emanuela Palmerini

المساهمون: Associazione Onlus Il pensatore: Matteo Amitrano, Associazione Italiana Contro le Leucemie - Linfomi e Mieloma, Foundation Corrado, [Ocadlikova,D, Lecciso,M, Cavo,M, Curti,A] IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy. [Ocadlikova,D, Cavo,M] Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy. [Broto,JM] Virgen del Rocio University Hospital, Institute of Biomedicine Research (IBIS), Seville, Spain. [Scotlandi,K] Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy. [Palmerini,E] Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., This study was supported by the Associazione Onlus ‘il Pensatore: Matteo Amitrano’, by Bologna AIL (Associazione Italiana contro le Leucemie), Section of Bologna, FATRO, Foundation Corrado and Bruno Maria Zaini-Bologna, Ocadlikova D., Lecciso M., Broto J.M., Scotlandi K., Cavo M., Curti A., Palmerini E.

المصدر: Frontiers in Immunology
Digital.CSIC. Repositorio Institucional del CSIC
instname
Frontiers in Immunology, Vol 12 (2021)

مصطلحات موضوعية: 0301 basic medicine, Sarcoma sinovial, Anatomy::Cells::Cells, Cultured::Cell Line::Cell Line, Tumor [Medical Subject Headings], Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [Medical Subject Headings], Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes::T-Lymphocyte Subsets::T-Lymphocytes, Regulatory [Medical Subject Headings], Células dendríticas, Programmed Cell Death 1 Receptor, Apoptosis, 178103907) [nivolumab (PubChem SID], Lymphocyte Activation, T-Lymphocytes, Regulatory, T regulatory cells (Tregs), Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, T-Lymphocyte Subsets, Inmunomodulación, Sunitinib, Dendritic cell (DC), Immunology and Allergy, Medicine, Nivolumab (PubChem SID: 178103907), Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::Lymphocyte Subsets::T-Lymphocyte Subsets [Medical Subject Headings], Immune Checkpoint Inhibitors, Original Research, Osteosarcoma, Synovial sarcoma, Phenomena and Processes::Immune System Phenomena::Immune System Processes::Lymphocyte Activation [Medical Subject Headings], medicine.anatomical_structure, Nivolumab, 030220 oncology & carcinogenesis, Sarcoma, Human, medicine.drug, lcsh:Immunologic diseases. Allergy, Linfocitos T reguladores, Immune Checkpoint Inhibitor, T cell, T regulatory cells, Immunology, Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Antigens, Differentiation::Antigens, Differentiation, T-Lymphocyte::Programmed Cell Death 1 Receptor [Medical Subject Headings], Protein Kinase Inhibitor, T-Lymphocyte Subset, Dendritic Cell, Tyrosine kinase inhibitor (TKI), Immunophenotyping, Immunomodulation, 5329102) [sunitinib (PubChem CID], Interferon-gamma, 03 medical and health sciences, Immune system, Phenomena and Processes::Immune System Phenomena::Immune System Processes::Immunomodulation [Medical Subject Headings], Cell Line, Tumor, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Immunologic Techniques::Immunologic Tests::Immunophenotyping [Medical Subject Headings], Humans, Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Growth Processes::Cell Proliferation [Medical Subject Headings], Protein Kinase Inhibitors, Cell Proliferation, Anatomy::Cells::Antigen-Presenting Cells::Dendritic Cells [Medical Subject Headings], business.industry, CD47, Apoptosi, Biomarker, Dendritic Cells, Sunitinib (PubChem CID: 5329102), medicine.disease, Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Death::Apoptosis [Medical Subject Headings], respiratory tract diseases, 030104 developmental biology, Cell culture, Cancer research, lcsh:RC581-607, business, Biomarkers

وصف الملف: application/pdf; ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a309f5aaad55f0c0d8ac38f6b453043Test
http://hdl.handle.net/10261/261717Test

المؤلفون: Ginevra Lolli, Michele Cavo, Alessandro Broccoli, Paolo Elia Coppola, Vittorio Stefoni, Cinzia Pellegrini, Lisa Argnani, Matteo Carella, Alice Morigi, Elena Sabattini, Laura Nanni, Pier Luigi Zinzani, Beatrice Casadei

المساهمون: Morigi A., Argnani L., Lolli G., Broccoli A., Pellegrini C., Nanni L., Stefoni V., Coppola P.E., Carella M., Casadei B., Sabattini E., Cavo M., Zinzani P.L.

المصدر: Hematological Oncology. 38:487-492

مصطلحات موضوعية: Adult, Male, Bendamustine, Cancer Research, medicine.medical_specialty, untreated, Nausea, Neutropenia, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Bendamustine Hydrochloride, Humans, Progression-free survival, bendamustine, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Remission Induction, Lymphoma, B-Cell, Marginal Zone, Hematology, General Medicine, Middle Aged, Prognosis, medicine.disease, marginal zone lymphoma, Lymphoma, Survival Rate, Regimen, Oncology, 030220 oncology & carcinogenesis, Female, Rituximab, medicine.symptom, business, Progressive disease, Follow-Up Studies, 030215 immunology, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c4812a6516480c01a3caa086832483dTest
https://doi.org/10.1002/hon.2773Test